300 related articles for article (PubMed ID: 17964677)
1. Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme.
Nikanjam M; Gibbs AR; Hunt CA; Budinger TF; Forte TM
J Control Release; 2007 Dec; 124(3):163-71. PubMed ID: 17964677
[TBL] [Abstract][Full Text] [Related]
2. Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme.
Nikanjam M; Blakely EA; Bjornstad KA; Shu X; Budinger TF; Forte TM
Int J Pharm; 2007 Jan; 328(1):86-94. PubMed ID: 16959446
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents.
Glickson JD; Lund-Katz S; Zhou R; Choi H; Chen IW; Li H; Corbin I; Popov AV; Cao W; Song L; Qi C; Marotta D; Nelson DS; Chen J; Chance B; Zheng G
Mol Imaging; 2008; 7(2):101-10. PubMed ID: 18706292
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel nanoparticles for the potential treatment of brain tumors.
Koziara JM; Lockman PR; Allen DD; Mumper RJ
J Control Release; 2004 Sep; 99(2):259-69. PubMed ID: 15380635
[TBL] [Abstract][Full Text] [Related]
5. Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies.
Rodrigues DG; Maria DA; Fernandes DC; Valduga CJ; Couto RD; Ibañez OC; Maranhão RC
Cancer Chemother Pharmacol; 2005 Jun; 55(6):565-76. PubMed ID: 15726368
[TBL] [Abstract][Full Text] [Related]
6. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.
Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z
Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815
[TBL] [Abstract][Full Text] [Related]
7. Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein.
Maletínská L; Blakely EA; Bjornstad KA; Deen DF; Knoff LJ; Forte TM
Cancer Res; 2000 Apr; 60(8):2300-3. PubMed ID: 10786698
[TBL] [Abstract][Full Text] [Related]
8. Use of nanoparticles for drug delivery in glioblastoma multiforme.
Jain KK
Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel.
McConathy WJ; Nair MP; Paranjape S; Mooberry L; Lacko AG
Anticancer Drugs; 2008 Feb; 19(2):183-8. PubMed ID: 18176115
[TBL] [Abstract][Full Text] [Related]
10. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
Xin H; Sha X; Jiang X; Zhang W; Chen L; Fang X
Biomaterials; 2012 Nov; 33(32):8167-76. PubMed ID: 22889488
[TBL] [Abstract][Full Text] [Related]
11. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release.
Park JS; Han TH; Lee KY; Han SS; Hwang JJ; Moon DH; Kim SY; Cho YW
J Control Release; 2006 Sep; 115(1):37-45. PubMed ID: 16935380
[TBL] [Abstract][Full Text] [Related]
12. Preparation of drug-low density lipoprotein complexes for delivery of antitumoral drugs via the low density lipoprotein pathway.
Lundberg B
Cancer Res; 1987 Aug; 47(15):4105-8. PubMed ID: 3607752
[TBL] [Abstract][Full Text] [Related]
13. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
Mandal BB; Kundu SC
Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
[TBL] [Abstract][Full Text] [Related]
14. Galactose-grafted chylomicron-mimicking emulsion: evaluation of specificity against HepG-2 and MCF-7 cell lines.
Jain V; Nath B; Gupta GK; Shah PP; Siddiqui MA; Pant AB; Mishra PR
J Pharm Pharmacol; 2009 Mar; 61(3):303-10. PubMed ID: 19222902
[TBL] [Abstract][Full Text] [Related]
15. A folate receptor-targeted emulsion formulation for paclitaxel.
Stevens PJ; Lee RJ
Anticancer Res; 2003; 23(6C):4927-31. PubMed ID: 14981947
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer.
Wang Y; Gao S; Ye WH; Yoon HS; Yang YY
Nat Mater; 2006 Oct; 5(10):791-6. PubMed ID: 16998471
[TBL] [Abstract][Full Text] [Related]
17. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
18. Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity.
Pulkkinen M; Pikkarainen J; Wirth T; Tarvainen T; Haapa-aho V; Korhonen H; Seppälä J; Järvinen K
Eur J Pharm Biopharm; 2008 Sep; 70(1):66-74. PubMed ID: 18555675
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes.
Meng S; Su B; Li W; Ding Y; Tang L; Zhou W; Song Y; Li H; Zhou C
Nanotechnology; 2010 Oct; 21(41):415103. PubMed ID: 20852356
[TBL] [Abstract][Full Text] [Related]
20. Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier.
Mooberry LK; Nair M; Paranjape S; McConathy WJ; Lacko AG
J Drug Target; 2010 Jan; 18(1):53-8. PubMed ID: 19637935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]